GeneDx Holdings Corp
WGS116.970USD
+4.480+3.98%
收盘 04/29, 16:00（美东）报价延迟15分钟
3.28B总市值
亏损市盈率 TTM
关于 GeneDx Holdings Corp 公司
GeneDx Holdings Corp. 是一家基因组学公司。该公司专注于提供个性化和可操作的健康见解，以指导诊断、指导治疗和改善药物发现。该公司的部门包括 GeneDx，包括 Legacy GeneDx 和 Legacy Sema4。GeneDx 部门主要提供儿科和罕见疾病诊断，重点是全外显子组和基因组测序，以及在较小程度上提供数据和信息服务。GeneDx 利用集成的实验室流程、软件工具和信息学功能组合来处理含脱氧核糖核酸 (DNA) 的样本，分析有关患者特定遗传变异的信息并为临床医生及其患者生成测试报告。GeneDx 提供各种基因诊断测试、筛查解决方案和信息。Legacy Sema4 诊断部门提供生殖和女性健康以及躯体肿瘤诊断测试和筛查产品。
公司简介
公司代码WGS
公司名称GeneDx Holdings Corp
上市日期Sep 04, 2020
成立日期2020
CEOMs. Katherine A. Stueland
员工数量1000
证券类型Ordinary Share
年结日Sep 04
公司地址333 Ludlow Street
城市STAMFORD
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编06902
电话18887291206
网址https://sema4.com/
公司代码WGS
上市日期Sep 04, 2020
成立日期2020
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
211.06K
+2.83%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
8.35K
+230.90%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
7.21K
+423.24%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
1.23K
-92.09%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
211.06K
+2.83%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
8.35K
+230.90%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
7.21K
+423.24%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
1.23K
-92.09%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Patients with third party insurance
234.70M
76.84%
Institutional customers
65.11M
21.32%
Other
3.29M
1.08%
Self pay patients
2.34M
0.77%
暂无数据
业务
地区
业务USD
名称
营收
占比
Patients with third party insurance
234.70M
76.84%
Institutional customers
65.11M
21.32%
Other
3.29M
1.08%
Self pay patients
2.34M
0.77%
股东统计
更新时间: 2月23日 周日
更新时间: 2月23日 周日
持股股东
股东类型
持股股东
股东统计
占比
Casdin Capital, LLC
12.29%
Corvex Management LP
8.67%
Summit Partners Public Asset Management, LLC
5.00%
Icahn School of Medicine at Mount Sinai
4.81%
OPKO Health Inc
4.80%
Other
64.42%
持股股东
股东统计
占比
Casdin Capital, LLC
12.29%
Corvex Management LP
8.67%
Summit Partners Public Asset Management, LLC
5.00%
Icahn School of Medicine at Mount Sinai
4.81%
OPKO Health Inc
4.80%
Other
64.42%
股东类型
股东统计
占比
Hedge Fund
34.25%
Investment Advisor/Hedge Fund
24.66%
Investment Advisor
19.91%
Corporation
10.79%
Research Firm
5.54%
Pension Fund
1.72%
Individual Investor
1.71%
Bank and Trust
0.32%
Sovereign Wealth Fund
0.24%
Other
0.85%
机构持股
更新时间: 3月4日 周二
更新时间: 3月4日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q1
342
28.65M
102.06%
+563.46K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
2023Q1
296
21.58M
684.27%
+3.47M
2022Q4
305
9.98M
86.27%
+851.42K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Casdin Capital, LLC
3.51M
12.5%
--
--
Dec 31, 2024
Corvex Management LP
2.47M
8.81%
--
--
Dec 31, 2024
Summit Partners Public Asset Management, LLC
1.43M
5.08%
+671.40K
+88.86%
Feb 05, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.89%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.88%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.08M
3.85%
+90.95K
+9.20%
Dec 31, 2024
Goldman Sachs & Company, Inc.
1.06M
3.79%
+34.15K
+3.32%
Dec 31, 2024
Oracle Investment Management, Inc.
1.02M
3.65%
-22.30K
-2.13%
Dec 31, 2024
The Vanguard Group, Inc.
1.00M
3.58%
+156.77K
+18.51%
Dec 31, 2024
William Blair Investment Management, LLC
670.00K
2.39%
+508.67K
+315.31%
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
Innovator IBD 50 Fund ETF
2.09%
SPDR S&P Health Care Services ETF
1.92%
Hypatia Women CEO ETF
0.62%
First Trust Active Factor Small Cap ETF
0.48%
Even Herd Long Short ETF
0.41%
iShares U.S. Healthcare Providers ETF
0.28%
iShares Micro-Cap ETF
0.24%
Principal U.S. Small-Cap ETF
0.23%
Vanguard US Momentum Factor ETF
0.18%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.15%
查看更多
Innovator IBD 50 Fund ETF
占比2.09%
SPDR S&P Health Care Services ETF
占比1.92%
Hypatia Women CEO ETF
占比0.62%
First Trust Active Factor Small Cap ETF
占比0.48%
Even Herd Long Short ETF
占比0.41%
iShares U.S. Healthcare Providers ETF
占比0.28%
iShares Micro-Cap ETF
占比0.24%
Principal U.S. Small-Cap ETF
占比0.23%
Vanguard US Momentum Factor ETF
占比0.18%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.15%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
公告日期
类型
比率
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1